The Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 252 participants.

Also called NCT03860220

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 252 participants (enrolled count) (from the registry)
Sponsor
Hyo-Soo Kim (from the registry)
Registry
  • NCT NCT03860220
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03860220. Randomized; no masking; primary purpose treatment. Start 2019-04-25 (actual); primary completion 2023-09-07 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Efficacy and Safety of Triple Therapy of Telmisartan/Amlodipine/Rosuvastatin
Condition
Hypertension
Condition
Dyslipidemias
Intervention (Drug)
NEWSTATIN TS
Intervention (Drug)
CADUET
Lead sponsor
Hyo-Soo Kim (class: other)

Record details

Record id
cardio:ct-nct03860220
Content hash
2ef31820bf182623cab5d849070a018ef559ed3f093675a097a8fb0a52ca430f